We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Surgery Improves Treatment of Head and Neck Cancer

By HospiMedica staff writers
Posted on 14 May 2008
A new surgical procedure which uses robotic surgery offers improved accuracy for surgeons, reduced post-operative pain for patients, and lessens the scarring, breathing problems, and damage to speech associated with treating head and neck cancers.

Researchers at the at the University of Alabama at Birmingham (UAB; Birmingham, AL, USA) adapted the da Vinci robotic surgery system--originally designed for operating on the lower and middle sections of the body--to the narrow spaces inside the head and neck by modifying operating techniques and robot-arm positions. More...
The increased surgical accuracy needed was achieved by the use of tiny cameras attached to the end of the da Vinci instruments. The magnified, three dimensional (3D) image gives doctors a greater field of vision than conventional open or laparoscopic surgery. Over 40 UAB patients have benefited from the new operation so far.

"This application takes robotic surgery to new places in the body,” said William Carroll, M.D., a head and neck surgeon at the UAB comprehensive cancer center. "There is an option for patients to have a more minimally invasive surgery, and one that could effectively remove the cancer while causing fewer side effects.”

The da Vinci System is a sophisticated robotic platform designed to expand the surgeon's capabilities by offering a minimally invasive option for major surgery. The system uses small incisions to introduce miniaturized wristed instruments and a high-definition 3D camera. The surgeon is seated at a control console, where he can view a high-resolution 3D image of the surgical site. At the same time, robotic and computer technologies scale, filter, and seamlessly translate the surgeon's hand movements into precise micro-movements of the da Vinci instruments. The system cannot be programmed, nor can it make decisions on its own. Rather, the da Vinci System requires that every surgical maneuver be performed with direct input from the surgeon. The da Vinci robotic surgery system was developed by Intuitive Surgical (Sunnyvale, CA, USA).


Related Links:
University of Alabama at Birmingham
Intuitive Surgical

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.